CIK 0001133416 · Non-accelerated filer<br>Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 043562325
- Phone
- 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-17 | FREEMAN KEVIN D Director | Purchase | +1,300 | $2.64 | $3K | 34,769 |
| 2024-10-16 | FREEMAN KEVIN D Director | Purchase | +5,000 | $2.70 | $14K | 33,469 |
| 2024-10-16 | FREEMAN KEVIN D Director | Purchase | +5,000 | $2.70 | $14K | 80,000 |
| 2024-08-23 | Zordani Richard A. Jr. Director | Purchase | +1,000 | $2.30 | $2K | 2,000 |
| 2024-08-23 | Zordani Richard A. Jr. Director | Purchase | +1,759 | $2.30 | $4K | 32,083 |
| 2024-08-22 | Zordani Richard A. Jr. Director | Purchase | +741 | $2.30 | $2K | 30,324 |
| 2024-08-01 | Jamil Khurram Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-08-01 | Jamil Khurram Chief Medical Officer | Grant or award · Restricted Stock Unit | +10,000 | 10,000 | ||
| 2024-07-22 | ELDRED KARY Director | Purchase | +400 | $2.39 | $956 | 49,713 |
| 2024-06-20 | FREEMAN KEVIN D Director | Purchase | +2,500 | $2.38 | $6K | 28,469 |
| 2024-04-30 | Zordani Richard A. Jr. Director | Purchase | +1,000 | $3.52 | $4K | 1,000 |
| 2024-04-24 | LEWIS JOEL President and CEO | Purchase | +1,000 | $3.39 | $3K | 2,000 |
| 2024-04-23 | CZIRR JAMES C 10% owner | Sale | −3,677 | $3.06 | $11K | 5,922,207 |
| 2024-04-22 | CZIRR JAMES C 10% owner | Sale | −21,323 | $3.06 | $65K | 5,925,884 |
| 2024-04-22 | FREEMAN KEVIN D Director | Purchase | +2,500 | $2.98 | $7K | 25,969 |
| 2024-04-09 | FREEMAN KEVIN D Director | Other acquisition | +2,063 | 18,063 | ||
| 2024-03-01 | LEWIS JOEL President and CEO | Grant or award | −152,584 | $1.96 | $299K | 897,716 |
| 2024-01-24 | Zordani Richard A. Jr. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-01-24 | Uihlein Richard E Director | Grant or award | +23,256 | $1.72 | $40K | 10,268,751 |
| 2024-01-24 | Uihlein Richard E Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 |
Page 14 of 15 · 291 trades